Drug Trial Radar · NCT02627196
Baroreflex Activation Therapy for Heart Failure
Last checked: Nov 20, 2026Latest source record: Mar 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,090
Actual
Start
Apr 19, 2016
Primary completion
Oct 2023
Study completion Oct 2023
Sponsor
- Lead sponsor
- CVRx, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 10, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therapy with the BAROSTIM NEO System in subjects with heart failure, defined as New York Heart Association (NYHA) functional Class III, left ventricular ejection fraction (LVEF) ≤ 35% and NT-proBNP\<1600 pg/ml despite being treated with the appropriate heart failure guideline directed therapy, excluding subjects eligible for or actively receiving Cardiac Resynchronization Therapy (CRT). The total trial duration is anticipated to be approximately 5 years; however, the duration of an individual subject enrollment will depend on when he or she entered the trial.
Conditions
- Heart Failure
Interventions
BAROSTIM NEO® SystemDevice
Medical ManagementDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Cardiovascular Mortality and Heart Failure MorbidityTime frame: From randomization until data-cut date for the endpoint analysis. Median follow-up was 3.6 years per patient.
- Major Adverse Neurological and Cardiovascular Events (MANCE)Time frame: 6 months post implant
- Percent Change in Log 10 Amino-terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) From Baseline to 6 Months Post-implantTime frame: 6 months post-implant
- Change to Six Minute Hall Walk (6MHW)Time frame: Baseline and 6 months post-implant
- Change in Minnesota Living With Heart Failure Quality of Life (MLWHF QOL) ScoreTime frame: Baseline and 6 months post-implant
Locations
92 sites in 2 countries. Site status is shown where the registry gives one.
Heart and Rhythm Solutions, PLLC
Chandler, Arizona
Chan Heart Rhythm Institute
Mesa, Arizona
Arizona Arrhythmia Research Center
Phoenix, Arizona
Phoenix Cardiovascular Research Group
Phoenix, Arizona
Cardiovascular Consultants, Ltd.
Phoenix, Arizona
Washington Regional Medical Center
Fayetteville, Arkansas
Central Cardiology Medical Center
Bakersfield, California
Chula Vista Cardiac Center
Chula Vista, California
Sharp Grossmont
Chula Vista, California
Sharp Chula Vista Medical Center
Chula Vista, California
John Muir Health Clinical Research Center
Concord, California
University of California, San Francisco - Fresno
Fresno, California
Herndon Surgery Center
Fresno, California
Glendale Adventist Medical Center
Glendale, California
Memorial Health Services
Laguna Hills, California
Los Alamitos Cardiovascular
Los Alamitos, California
Southern California Permanente Medical Group
Los Angeles, California
University of Southern California
Los Angeles, California
Advanced Cardiovascular Specialists
Mountain View, California
Hoag Memorial Hospital
Newport Beach, California
UC Irvine Health
Orange, California
Desert Heart Regional Medical Center
Palm Springs, California
Huntington Hospital
Pasadena, California
Dignity Health
Sacramento, California
University of California San Francisco
San Francisco, California
Bonometti, Inc
Santa Barbara, California
Adventist Heart Institute
St. Helena, California
North Colorado Medical Center
Greeley, Colorado
Medical Center of the Rockies Research
Loveland, Colorado
Atlantic Clinical Research Center - Cardiology
Atlantis, Florida
Clearwater Cardiovascular Consultants
Clearwater, Florida
Holy Cross Hospital
Fort Lauderdale, Florida
Memorial Cardiovascular Institute
Hollywood, Florida
AdventHealth Orlando
Orlando, Florida
Avanza Medical Research Center
Pensacola, Florida
University of South Florida
Tampa, Florida
Mercer University
Macon, Georgia
WellStar Medical Group
Marietta, Georgia
St. Alphonsus Medical Center
Boise, Idaho
NorthShore University Health System
Evanston, Illinois
Showing 40 of 92 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.